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Abstract
The integrin CD103 is the aE chain of integrin aEb7 that is important in the
maintenance of intraepithelial lymphocytes and recruitment of T cells and
dendritic cells (DC) to mucosal surfaces. The role of CD103 in intestinal
immune homeostasis has been well described, however, its role in allergic air-
way inflammation is less well understood. In this study, we used an ovalbu-
min (OVA)-induced, CD103-knockout (KO) BALB/c mouse model of
experimental allergic airways disease (EAAD) to investigate the role of CD103
in disease expression, CD4+ T-cell activation and DC activation and function
in airways and lymph nodes. We found reduced airways hyper-responsiveness
and eosinophil recruitment to airways after aerosol challenge of CD103 KO
compared to wild-type (WT) mice, although CD103 KO mice showed
enhanced serum OVA-specific IgE levels. Following aerosol challenge, total
numbers of effector and regulatory CD4+ T-cell subsets were significantly
increased in the airways of WT but not CD103 KO mice, as well as a lack of
DC recruitment into the airways in the absence of CD103. While total airway
DC numbers, and their in vivo allergen capture activity, were essentially nor-
mal in steady-state CD103 KO mice, migration of allergen-laden airway DC
to draining lymph nodes was disrupted in the absence of CD103 at 24 h after
aerosol challenge. These data support a role for CD103 in the pathogenesis of
EAAD in BALB/c mice through local control of CD4+ T cell and DC subset
recruitment to, and migration from, the airway mucosa during induction of
allergic inflammation.
Introduction
The integrin CD103 is the a chain of integrin aEb7, an
adhesion molecule that mediates cell binding primarily to
the epithelial transmembrane glycoprotein E-cadherin
(Agace et al. 2000). CD103 expression has been well char-
acterized on T cells in the intestinal tract of mice, where
the majority (>90%) of intraepithelial T cells and a large
proportion (40–50%) of mucosal T cells express CD103,
compared to a small proportion (<15%) in the blood or
spleen (Agace et al. 2000). In humans, CD103 is also
preferentially expressed on CD4+ and CD8+ T cells in
gut, where up to 80% of T cells can be CD103+ compared
to less than 5% of T cells in peripheral blood (Cerf-Ben-
sussan et al. 1987). The CD103 molecule has been impli-
cated in the retention of T cells in the gut epithelium and
also in the skin (El-Asady et al. 2005; Suffia et al. 2005),
although additional studies have shown that CD103 is
not essential for CD8+ T-cell accumulation in the intes-
tine, leading others to suggest that alternative ligands for
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CD103 may exist (Lefrancois et al. 1999; Strauch et al.
2001).
Beyond the T-cell compartment, CD103 is reciprocally
expressed with CD11b on subsets of dendritic cells (DC)
in most lymphoid and nonlymphoid tissues of mice,
including the intestinal mucosa and mesenteric lymph
nodes where CD103+ DC are proposed to play a role in
the regulation of intestinal inflammation via interactions
with CD4+ regulatory T cells (Annacker et al. 2005; Gin-
houx et al. 2009). In the lung, respiratory tract DC
(RTDC) can be broadly classified into two major subsets
based on the reciprocal expression of CD11b and CD103:
CD11bhi (CD103-) RTDC express higher levels and a
greater range of chemokines than CD103+ (CD11blo)
RTDC, while CD103+ RTDC express higher levels of Lan-
gerin and tight junction proteins and are thought to
extend dendrites through epithelial tight junctions and
into the airway lumen for antigen sampling (Sung et al.
2006; Beaty et al. 2007), (Hammad and Lambrecht 2008).
Additionally, CD103+ DC appear to be specialized for
cross-presentation of inhaled proteins and viral antigens
to CD8+ T cells, and have been shown to produce high
levels of the Th1-promoting cytokine IL-12 (Sung et al.
2006; Helft et al. 2012; Nakano et al. 2012). In contrast,
we have shown that CD11bhi airway mucosal RTDC
appear to preferentially capture inhaled proteins under
steady-state conditions for transport to airway draining
lymph nodes (von Garnier et al. 2007; Wikstrom and
Stumbles 2007), with others proposing that this subset of
DC are specialized for presentation of inhaled antigens to
CD4+ T cells in lymph nodes in the steady-state (del Rio
et al. 2007). However, we have also shown that CD103+
(CD11blo) airway mucosal RTDC dramatically increase
their capacity for inhaled antigen capture during allergic
airways inflammation and promote allergen-specific CD4+
T-cell proliferation in airway draining lymph nodes (von
Garnier et al. 2007).
To date, however, there is little information on the role
of CD103-expressing cells in the pathogenesis of allergic
airways inflammation that underlies allergic asthma. The
hallmarks of allergic asthma include airways hyper-
responsiveness (AHR) to inhaled allergen, with concomi-
tant cellular infiltration of eosinophils, B cells, Th2
effector cells and RTDC, elevated allergen-specific IgE and
IgG1 antibody production and increased production of
the pathogenic Th2-cytokines IL-4, IL-5 and IL-13 (Edel-
son et al. 2010). A number of studies have highlighted
the central roles of both RTDC and CD4+ T cells in the
pathogenesis of the disease, with RTDC required for
inhaled allergen capture at the airway mucosa and trans-
port to airway draining lymph node (ADLN) for activa-
tion of allergen-specific CD4+ Th2 cells that mediate
many of the clinical characteristics of the disease
including IgE production, AHR and airway eosinophil
recruitment (Holt et al. 2008).
In this study, we have examined the role of CD103 in
the development of experimental allergic airways disease
(EAAD) in a BALB/c mouse model of OVA sensitization
and airways challenge. Although CD103 was not required
for systemic priming of allergen-specific IgE, CD103
expression was required for the local expression of the
clinical signs of allergic airways inflammation, including
CD4+ T-cell influx into the airway mucosa, induction of
AHR and airways eosinophilia. Importantly, we show
that this was due to alterations in the capacity of airway
mucosal RTDC to capture and transport inhaled allergen
to draining lymph nodes, and for airway recruitment
(but not lymph node priming) of effector CD4+ T-cell
subsets.
Materials and Methods
BALB/c mouse model of EAAD
Eight-week old SPF female BALB/c mice were from the
Animal Resource Centre, Perth, WA, Australia. BALB/c
CD103-/- (C. 129S2-Itgaetm1Cmp/J) mice were purchased
from Jackson Laboratories (Bar Harbor, ME) and bred at
the Telethon Kids Institute. To induce EAAD, mice were
sensitized by intraperitoneal (i.p.) injection of 20 lg
ovalbumin (OVA) in 200 lL AlOH3 on days 0 and 14,
then received 1% OVA aerosols for one or three consecu-
tive days, or 50 lg OVA in 50 lL LPS-free saline intra-
nasally (i.n.) starting on day 21 as described (von
Garnier et al. 2007). Control mice were sensitized to
OVA as above and challenged with LPS-free saline deliv-
ered as aerosol or i.n. All animal experiments were
approved by the Telethon Kids Institute Animal Ethics
Committee (AEC #240) operating under the National
Health and Medical Research Council of Australia
guidelines.
BALF and serum collection
A duration of 24 h after the final aerosol, broncheoalveo-
lar lavage fluid (BALF) was collected by flushing 1 ml of
PBS into the lung as described (Burchell et al. 2009).
Cells were cytocentrifuged onto glass slides and stained
with DIFF-Quik Stain (Lab Aids, Narrabeen, NSW, Aus-
tralia). Sera was collected 24 h after the final aerosol by
cardiac heart puncture and stored at 20°C.
Assessment of AHR
A duration of 24 h after aerosol challenge, a modified
low-frequency forced oscillation technique (FOT) was
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used to measure change in respiratory input impedance
(Zrs) in response to increasing doses of methacholine
(0.1–30 mg/mL) as described previously (Burchell et al.
2009). The constant phase model was used to partition
Zrs into components representing the conducting airway
(airways resistance).
Trachea and lymph node single cell
preparations
Trachea and airway draining lymph node (ADLN) were
prepared as single cell suspensions as described (von Gar-
nier et al. 2005). Briefly, pooled (5 mice/group) trachea
or ADLN were collagenase digested (Type IV; 1.5 mg/mL;
Worthington Biochemical, Lakewood, NJ) and DNAse
(0.1 mg/mL; Sigma Aldrich, Sydney, NSW, Australia),
then washed in glucose potassium sodium buffer (GKN)
as previously described (von Garnier et al. 2005).
Flow cytometry
Cells were FcR blocked (2.4G2; BD Biosciences) prior to
adding fluorochrome-labeled monoclonal antibodies
(mAbs) to I-A/I-E (2G9); CD11c (N418), CD11b (M1/
70), CD8a (53–6.7), or CD103bio (M290) to identify DC,
and CD3, CD4, CD62L and CD44 or CD3, CD4, CD25
(BD Biosciences, San Jose, CA) together with FoxP3
intracellular staining kit (eBiosciences, San Diego, CA) to
identify CD4+ T-cell subsets. All mAbs were used as direct
conjugates to FITC, PE, PE-Cy7, APC, APC-Cy7, or bio-
tin and streptavidin-PE-Cy5 (BD Biosciences). Samples
were analyzed using an LSRII flow cytometer (BD Bio-
sciences) and FlowJo software (FlowJo, Ashland, OR,
USA)
Assessment of inhaled antigen uptake
in vivo
Mice were lightly anesthetized with gaseous isofluorane
and then received 20 lg OVA-conjugated Alexa Fluor 647
(OVA-A647; Molecular Probes; Eugene, OR, USA) in
50 lL endotoxin-free saline delivered i.n. on d21 follow-
ing sensitization (Wikstrom and Stumbles 2007). Mice
were killed at indicated time points after OVA-A647
administration by sodium pentobarbital overdose, and
trachea and ADLN tissue were harvested and analyzed by
flow cytometry.
Statistical analysis
Data were analyzed by unpaired, one- or two-tailed
Mann–Whitney U-test using Prism 6 software (GraphPad,
San Diego, CA).
Results
CD103 is required for the development of
local airways hyper-responsiveness and
eosinophilia, but not systemic antigen-
specific IgE production, during induction of
EAAD in BALB/c mice
To examine the potential role of CD103 in the develop-
ment of the hallmark clinical features of allergic airways
inflammation, we used a well-established model of OVA-
induced EAAD in which adult BALB/c wild-type (WT) or
CD103 knock-out (KO) mice were sensitized i.p. with
OVA in AlOH3 (OVA-Alum) on days 0 and 14, then
OVA aerosol-challenged with OVA on days 21, 22, and
23. We then examined the mice for development of circu-
lating OVA-specific IgE, airways hyper-responsiveness
(AHR), and BALF inflammatory cells 24 h later (Fig. 1).
Notably, OVA-sensitized and aerosol-challenged KO mice
developed significantly elevated levels of circulating OVA-
specific IgE (Fig. 1A; P < 0.01), but significantly lower
levels AHR in response to inhaled methacholine (Fig. 1B;
P < 0.05), when compared to WT mice. Nonsensitized
and unchallenged control KO mice demonstrated a trend
for increased baseline AHR to methacholine challenge
compared to WT control mice. Unlike WT mice, sensiti-
zation and aerosol challenge of KO mice did not further
increase AHR relative to baseline nonsensitized and
unchallenged control levels (data not shown). Next, we
examined the development of BALF cellular inflammation
in response to allergen challenge by comparing the per-
centages (Fig. 1C) and total numbers (Fig. 1D) of macro-
phages, eosinophils, neutrophils, and lymphocytes in
BALF of OVA-sensitized and challenged WT and KO
mice as compared to OVA-sensitized and saline-chal-
lenged controls. In saline-challenged mice, there were no
significant differences in the percentages of macrophages
and eosinophils in BALF between WT and KO mice,
however, KO mice showed a slightly increased percentage
of neutrophils (P < 0.05), and decreased percentage of
lymphocytes (P < 0.01), when compared to WT mice
(Fig. 1C). Following OVA-challenge, both WT and KO
mice developed increased percentages of eosinophils
(P < 0.01) and neutrophils (P < 0.01 and 0.05, respec-
tively) and decreased percentages of macrophages
(P < 0.05) compared to saline controls, with the percent-
ages of macrophages significantly lower in WT compared
to KO OVA-challenged mice (Fig. 1C). For total cell
numbers, saline-challenged KO mice showed significantly
increased numbers of macrophages (P < 0.05) and neu-
trophils (P < 0.05) compared to WT mice, with no differ-
ences in eosinophil or lymphocyte numbers between
saline-challenged WT and KO mice (Fig. 1D). Following
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OVA-challenge, WT mice developed significantly elevated
numbers of eosinophils (P < 0.01) and neutrophils
(P < 0.01) compared to saline-challenge controls, whereas
KO mice failed to develop elevated levels of either of
these cell types compared to their saline-challenged coun-
terparts (Fig. 1D). Macrophage numbers were elevated in
OVA-challenged KO compared to WT mice (P < 0.05),
but decreased compared to saline-challenged controls in
both WT (P < 0.01) and KO (P < 0.05) mice, while no
differences in lymphocyte numbers were observed for any
group (Fig. 1D).
In summary, these data indicate that CD103 was
required for the development of local, airway-specific
clinical signs of allergic airways inflammation in adult
BALB/c mice following aeroallergen challenge, including
AHR and BALF eosinophil responses. However, absence
Figure 1. Clinical parameters of OVA-induced experimental allergic airways disease in CD103/ and WT BALB/c mice. Adult BALB/c WT and
CD103 KO mice were sensitized with OVA in aluminum hydroxide i.p. on days 0 and day 14, then challenged with either OVA or saline
aerosols on days 21–23. (A) Sera were collected 24 h after last aerosol and OVA-specific IgE determined by passive cutaneous anaphylaxis
(PCA) as described in Materials and Methods (2 independent experiments, n > 6 mice/group/experiment). (B) Mice received a single OVA or
saline aerosol challenge on day 21, 24 h prior to methacholine challenge (MCh) on day 22 and measurement of airways hyper-responsiveness
(AHR) by forced oscillation technique as described in Materials and Methods. Data indicate airways resistance, in response to 30 mg/ml MCh, in
WT and CD103 KO mice relative to their respective OVA-sensitized control. (Two independent experiments, n = 8 to 12 mice/group). (C) and
(D) BALF was collected 24 h after final aerosol and the percentages (C) and total numbers (D) of macrophages, eosinophils, neutrophils, and
lymphocytes determined by differential staining and counting as described in Materials and Methods (n = 5 mice/group; data are means +/
SEM). *P < 0.05, **P < 0.01 by two-tailed Mann–Whitney U-test. AHR, airways hyper-responsiveness; BLF, Broncheoalveolar lavage fluid; WT,
wild type; KO, knockout; OVA, ovalbumin.
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of CD103 did not impact on systemic allergen sensitiza-
tion, as evidenced by a robust, and even enhanced, sys-
temic antigen-specific IgE response in CD103 KO mice.
CD103 is required for effector and
regulatory CD4+ T-cell recruitment to the
airway mucosa following antigen-
sensitization and aerosol challenge
Previous studies have shown an association between
recruitment of CD4+ T cells into the airways and the
development of allergic asthma in humans, and a require-
ment for CD4+ T-cell activation and airway recruitment
in the development of EAAD in BALB/c mice (Huh et al.
2003; Zosky et al. 2009). Given that CD103 is expressed
on lymphocytes and that E-cadherin is expressed on air-
way epithelial cells, it has been proposed that CD103 may
be required for retention of pathogenic and regulatory
CD4+ T cells within the airway epithelium (Nawijn et al.
2011). Therefore, we examined percentages and total
numbers of CD4+ T-cell subsets (total CD4+ T cells,
CD4+ CD25+ FoxP3+ regulatory T cells (Treg), CD4
+
CD25+ FoxP3- effector T cells (Teff)) in the main con-
ducting airways of WT and CD103 KO mice by flow
cytometry following OVA-sensitization and challenge
(Fig. 2). No differences in the percentages of total CD4+
T cells were observed in the airways of sensitized WT
compared to KO mice challenged with saline or OVA
(Fig. 2A, left panel). In contrast, the percentage of CD4+
Treg cells increased in the airways of WT mice after OVA-
challenge compared to saline-challenged WT controls
(P < 0.05). A similar increase in CD4+ Treg cells was not
observed in KO mice, where the percentage of Treg
remained significantly lower than for WT mice after
OVA-challenge (Fig. 2A, middle panel; P < 0.05). Simi-
larly, the percentages of CD4+ Teff cells also increased in
the airways of WT mice after OVA-challenge compared
to saline-challenged WT controls (P < 0.05). Again, this
increase was not observed in OVA-challenge KO mice
compared to saline-challenged KO controls (Fig. 2A, right
panel).
In terms of total CD4+ T-cell numbers, these were
marginally but not significantly increased in the airways
of OVA- compared to saline- challenged WT mice, and
significantly decreased in OVA-challenged KO mice com-
pared to OVA-challenged WT mice (P < 0.05) and sal-
ine-challenged KO mice (P < 0.05) (Fig. 2B, left panel).
Similarly, there was a nonsignificant increase in total
numbers of CD4+ Treg cells in the airways of OVA- com-
pared to saline- challenged WT mice, and a significant
decrease in OVA-challenged KO compared to WT mice
(P < 0.05) (Fig. 2B, middle panel). Finally, a significant
increase in the numbers of CD4+ Teff cells was observed
in the airways of OVA- compared to saline-challenged
WT mice (P < 0.05), while there was a significant
decrease in the numbers of Teff cells in the airways of
OVA-challenged KO compared to WT mice (P < 0.05)
(Fig. 2B, right panel).
In summary, these data support a role for CD103 in
the recruitment and/or retention of CD4+ T-cell subsets
into the airways following allergen sensitization and chal-
lenge, which correlates with a lack of AHR and BALF
eosinophils in the absence of CD103 described above.
CD103 is required for recruitment of
dendritic cell subsets into the airways
following aeroallergen challenge, but does
not influence aeroallergen capture or DC
emigration to draining lymph nodes
A central role for airway mucosal dendritic cells (AMDC)
in the capture of inhaled antigens, and subsequent traffic
to airway draining lymph nodes (ADLN) for surveillance
by na€ıve CD4+ T cells, has been well established (Holt
et al. 2008; Lambrecht and Hammad 2010). Furthermore,
we and others have previously shown that subsets of
AMDC, distinguished by their differential expression of
CD11b and/or CD103 (CD11bhi CD103- and CD11blo
CD103+), differ in their capacities for allergen capture
and trafficking to ADLN in mice (Sung et al. 2006; Beaty
et al. 2007; von Garnier et al. 2007). Therefore, we rea-
soned that the deficiencies in CD4+ T-cell recruitment to
the airways described above may have been a consequence
of altered AMDC numbers in the airways and/or their
allergen trafficking and presentation in the ADLN.
To address this, we first determined the percentages and
numbers of total, CD11bhi and CD11blo AMDC in the air-
ways of sensitized WT and KO mice after saline- and
OVA-challenge (Fig. 3A). Importantly, the total percent-
age of CD11c+ MHC II+ AMDC was similar in WT and
KO mice after both saline and OVA-challenge, indicating
that a lack of CD103 did not influence the percentages of
AMDC in the airways (Fig. 3A, left panels). Likewise,
despite lacking CD103, the proportions of CD11bhi and
CD11blo AMDC subsets in KO mice were similar to those
of WT mice after both saline- and OVA-challenge
(Fig. 3A, right panels), confirming that a lack of CD103
did not influence total numbers or the distribution of
CD11b-expressing AMDC subsets. Next, we analyzed the
total numbers of AMDC and AMDC subsets in the air-
ways of WT and KO mice after saline- or OVA-challenge
(Fig. 3B). In WT mice, numbers of total AMDC showed a
significant increase after OVA- compared to saline-chal-
lenge (P < 0.05), however, no increases in total AMDC
were observed in KO mice after OVA-challenge, the num-
bers of which remained significantly decreased below WT
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mice (P < 0.05) (Fig. 3B, left panel). The changes in
AMDC numbers appeared to be equally distributed across
subsets of AMDC, with similar increase in both the
CD11blo (Fig. 3B, middle panel; P < 0.05) and CD11bhi
(Fig. 3, right panel; P < 0.05) AMDC subsets in OVA-
compared to saline-challenged WT mice, whereas no
increase in either AMDC subset was observed in OVA-
challenged KO mice (Fig. 3B, middle and right panels).
Next, we examined inhaled OVA capture by WT and
CD103 KO mouse AMDC, and the CD11blo and CD11bhi
subsets early (2 h) and late (24 h) after allergen challenge,
by tracking uptake of fluorescently labeled OVA-Alexa
(A) 647 delivered i.n. into OVA-sensitized WT and KO
mice (Fig. 4). We have previously shown that, given the
rapid turn-over rates (<24 h) of AMDC (von Garnier
et al. 2005), the timing for these capture experiments is
important, as early time points will indicate local antigen
capture by resident AMDC, while at later time points,
these cells will have left the airways and migrated to
ADLN (Wikstrom and Stumbles 2007). Inhaled OVA-
A647 was captured by a similar percentage of total
AMDC in WT and KO mice at 2 h post challenge
(Fig. 4A, left panel), with the majority of uptake by the
CD11bhi AMDC subset (Fig. 4A, right panel) as com-
pared to the CD11blo AMDC subset (Fig. 4A, middle
panel) in both strains of mice. In contrast, a smaller per-
centage of total, CD11blo and CD11bhi AMDC were posi-
tive for OVA-A647 at the 24 h time point, consistent
with these cells having trafficked to the ADLN (Fig. 4A).
A similar pattern was observed for total numbers of
OVA-A647+ AMDC subsets, with similar uptake by total
(Fig. 4B, left panel) and CD11bhi (Fig. 4B, right panel)
AMDC of WT and KO mice at 2 h post-OVA exposure,
and little uptake by CD11blo AMDC at this time point
(Fig. 4B, middle panel). Again, at 24 h, there were very
few numbers of OVA-A647+ AMDC remaining in the air-
ways of either mouse strain, although numbers of OVA+
total AMDC of KO mice were lower than WT mice at the
24 h time point (Fig. 4B, left panel).
In summary, these data indicate that CD103 was not
required for baseline homeostasis of AMDC numbers in
saline-challenged mice, whereas AMDC failed to be either
recruited to, or retained within, the airways in the
absence of CD103 following OVA challenge. However,
similar percentages and numbers of AMDC captured
inhaled OVA in both WT and KO mice at 2 h following
OVA challenge, with the bulk of inhaled antigen captured
by the CD11bhi AMDC subset in both WT and KO mice,
consistent with our previous data (von Garnier et al.
2007). Furthermore, at 24 h, the rate of egress of OVA+
AMDC from the airways was similar in both mouse
strains, and possibly enhanced in CD103 KO mice.
Trafficking of inhaled antigen to airway
draining lymph nodes by migratory airway
DC is reduced in the absence of CD103 in
OVA-sensitized and challenged mice
Delivery of inhaled antigens from the airways to the
ADLN by antigen-loaded migratory DC is required for
Figure 2. Conducting airway CD4+ T-cell subset percentages and numbers in OVA-sensitized and challenged BALB/c WT and CD103/ mice.
Adult BALB/c WT and CD103 KO mice were sensitized and challenged with OVA or saline as described for Figure 1. At 24 h after final aerosol,
trachea were harvested, and single cell suspensions prepared and analyzed by flow cytometry for total CD4+ T cells, CD4+ FoxP3+ CD25+
regulatory T cells (Treg), and CD4
+ FoxP3 CD25+ effector T cells (Teff). (A) Percentages and (B) total numbers of total, Treg and Teff CD4
+ T cells
in tracheas of saline or OVA-challenged WT or CD103 KO mice. (data are a minimum of three independent experiments with n = 5 mice/group
in pooled samples; means +/ SEM). *P < 0.05, by one-tailed Mann–Whitney U-Test; WT, wild type; KO, knockout; OVA, ovalbumin.
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activation of naive antigen-specific T cells and their hom-
ing to the airway mucosa to induce inflammation (Holt
et al. 2008; Lambrecht and Hammad 2010). In lymph
nodes, DC can be divided into CD8a migratory DC and
CD8a+ resident DC, the former being the primary driver
of CD4+ T-cell responses via classical MHC Class II
restricted presentation pathways, while the latter act in
part to cross-present soluble antigens to CD8+ T cells
(Miller et al. 2012). Therefore, we next examined the traf-
fic of inhaled antigen to ADLN, and its distribution
among migratory (CD8a) and resident (CD8a+),
CD11bhi or CD11blo ADLN DC subsets, by i.n. exposure
of OVA-sensitized wild-type and KO mice to fluorescently
labeled OVA-Alexa 647 and determining the distribution
of OVA among ADLN DC subsets 2 h and 24 h later
(Fig. 5A). Total ADLN cell numbers at 24 h post OVA-
challenge were significantly increased in the WT OVA-
challenged compared to the WT saline challenged
(11.3 9 106 cells/ADLN and 3.8 9 106 cells/ADLN,
respectively; P < 0.001), no significant increases were
observed for KO mice (data not shown). While the
percentages of DC in the ADLN did not change signifi-
cantly between saline- and OVA-challenged WT or KO
mice (Fig. 5A and B, left panel), the total DC number per
lymph node was significantly increased in OVA-chal-
lenged compared to saline-challenged WT mice
(P < 0.05) (Fig. 5B, right panel). Total DC numbers were
also elevated in OVA-challenged KO mice compared to
saline-challenged controls, however, this was not statisti-
cally significant (Fig. 5B, right panel). In addition, there
were no significant differences in the absolute percentages
of CD8a CD11blo and CD8a- CD11bhi or CD8a+
CD11bhi and CD8a+ CD11blo ADLN DC between OVA-
challenged WT and KO mice at 2 h and 24 h post-OVA
challenge (Fig. 5A).
Next, we determined the percentage of each DC pop-
ulation positive for OVA-A647 at 2 h and 24 h after
i.n. delivery into OVA-sensitized mice (Figs. 5C and
5D). For both WT and KO mice, the percentages of
OVA-A647+ CD8a- CD11blo and CD8a- CD11bhi migra-
tory ADLN DC significantly increased at 24 h compared
to 2 h post-OVA challenge, although the percentage
Figure 3. Airway dendritic cell subset phenotype and numbers in OVA-sensitized and challenged BALB/c WT and CD103/ mice. Adult BALB/
c WT and CD103 KO mice were sensitized and challenged with OVA or saline as described for Figure 1, tracheas harvested 24 h after final
aerosol and single cells analyzed by flow cytometry for expression of CD11b, CD11c, MHC Class II (I/A-E), and CD103. (A) Gating strategy for
identification of airway DC populations by flow cytometry in tracheas isolated from saline- (left panels) and OVA- (right panels) challenged WT
and CD103 KO mice. Airway DC were identified as I/A-Ehi/CD11chi after forward and side scatter gating (left panels, oval gate), then
subsequently analyzed for expression of CD11b and CD103 (right panels) (representative plots of three experiments, using cells obtained from
pools of 5 mice/experiment). (B) Numbers of total DC per trachea (left panel), CD11blo DC and CD11bhi DC in WT and KO mice post saline-
and OVA-challenge. (n = 5 mice/group with pooled samples, for three independent experiments, data are means +/ SEM) *P < 0.05 by one-
tailed Mann–Whitney U-test. WT, wild type; KO, knockout; OVA, ovalbumin.
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OVA-A647+ DC were lower in KO compared to WT
mice at the 24 h time point. (Fig. 5C, left panels;
P < 0.05). Interestingly, although at low levels, the per-
centages of OVA-A647+ CD8a CD11blo and CD8a-
CD11bhi ADLN DC at the 2 h time point were signifi-
cantly elevated in WT compared to the KO mice
(Fig. 5C, left panels; P < 0.05). No significant changes
in the percentages of OVA-A647+ CD8a+ CD11blo resi-
dent ADLN DC were observed at 2 h or 24 h post
challenge, however, there was a minor although signifi-
cant increase in the percentage of OVA-A647+ CD8a+
CD11bhi resident ADLN DC in KO compared to WT
mice at 24 h post challenge (Fig. 5C, right panels). A
similar trend was observed for total numbers of OVA-
A647+ ADLN DC (Fig. 5D), although in this case, the
total numbers of OVA-A647+ CD8a CD11blo migra-
tory ADLN DC were significantly lower in KO com-
pared to WT mice at the 24 h time point (Fig. 5D, left
panel; P < 0.05).
In summary, these data indicate that in WT mice,
inhaled OVA is carried to ADLN by both the CD11blo
and CD11bhi migratory CD8a- ADLN DC subsets within
24 h after OVA exposure, with some OVA appearing as
early as 2 h, consistent with our previous findings (Wik-
strom et al. 2006). In contrast, both the percentage and
total numbers of OVA+ migratory CD8a- ADLN DC were
reduced in OVA-sensitized and challenged KO mice, both
for the CD11blo and CD11bhi subsets at 2 h and 24 h
post-OVA exposure.
CD4+ T-cell subset responses are normal or
enhanced in airway draining lymph nodes
of sensitized and challenged mice in the
absence of CD103
The OVA trafficking data described above suggested that
altered migration of antigen-bearing airway DC to the
ADLN in KO mice may have an impact on CD4+ T-cell
priming and the generation of activated CD4+ effector
T-cell subsets. Therefore, we next examined the percent-
ages and total numbers of total CD4+ T cells, CD25+
FoxP3+ regulatory CD4+ T cells (Treg), and CD25
+ FoxP3-
effector CD4+ T cells (Teff) in the airway draining lymph
nodes (ADLN) of OVA-sensitized KO and WT mice fol-
lowing OVA-challenge (Fig. 6). There were no changes in
the percentages of total CD4+ T cells, CD4+ CD25+
FoxP3+ Treg, or CD4
+ CD25+ FoxP3- Teff in response to
OVA-challenge in either WT or KO mice compared to
their saline-challenged controls (Fig. 6A). However, there
was a significantly increased percentage of total CD4+ T
cells in OVA-challenged KO mice compared to OVA-
challenged WT mice (P < 0.05) (Fig. 6A, left panel). For
total cell numbers, OVA-challenged WT mice showed no
differences to saline-challenged WT control mice for any
of the CD4+ T-cell subsets (Fig. 6B). However, there were
significantly increased numbers of total CD4+ T cells
(Fig. 6B, left panel) and CD4+ CD25+ FOXP3+ Treg cells
(Fig. 6B, middle panel) in the OVA-challenged KO mice
compared to saline-challenged KO control mice.
Figure 4. Inhaled antigen capture by airway dendritic cell subsets in BALB/c WT and CD103/ mice. Adult BALB/c WT and CD103 KO mice
were sensitized with OVA in alum i.p. on days 0 and 14, and on day 21 were challenged with 50 lg OVA-A647 in 50 lL saline p.n. Trachea
were then harvested at 2 h and 24 h post challenge and DC analyzed by flow cytometry as described for Figure 2, along with assessment of
percentages and numbers of DC containing OVA-A647. (A) OVA uptake presented as the percentage of OVA-A647+ cells among total DC,
CD11blo DC, and CD11bhi DC per trachea. (B) Antigen capture presented as total number of OVA-A647+ total DC, CD11blo DC, and CD11bhi
DC per trachea. (data are from three independent experiments with n = 5 mice/group in pooled samples; means +/SEM) *P < 0.05 by
one-tailed Mann–Whitney U-Test. WT, wild type; KO, knockout; OVA, ovalbumin.
2016 | Vol. 4 | Iss. 21 | e13021
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Figure 5. Traffic of inhaled antigen to airway draining lymph nodes in OVA-sensitized BALB/c WT and CD103-/- mice. Adult BALB/c WT and
CD103 KO mice were sensitized with OVA in alum i.p. on days 0 and 14, and on day 21 were challenged with 50 lg OVA-A647 in 50 lL
saline p.n. Airway draining lymph nodes (ADLN) were then harvested at 2 h and 24 h post challenge and DC analyzed by flow cytometry as
described for Figure 2, including labeling for CD8a- migratory and CD8a+ resident DC, along with assessment of percentages and numbers of
DC containing OVA-A647. (A) Gating strategy for identification of ADLN DC populations by FACS in saline and OVA-challenged WT and
CD103 KO mice. DC were identified as I–A/Ehi CD11chi cells (left panels), and then subsequently gated for expression of CD8a and CD11b
(right panels). (B) Total DC percentages and numbers per ADLN in WT and CD103 KO mice post saline- and OVA-challenge. (C) Percentages of
CD8a-CD11blo, CD8a-CD11bhi, CD8a+CD11blo, CD8a+CD11bhi ADLN DC subpopulations positive for OVA-Alexa 647, presented as mean
percentage frequency +/ SEM of total cells in ADLN (n = 5 mice/group with pooled samples, for three independent experiments) (D) Total
numbers of CD8a-CD11blo, CD8a-CD11bhi, CD8a+CD11blo, CD8a+CD11bhi ADLN DC subpopulations positive for OVA-Alexa 647, presented as
mean total number positive cells +/ SEM per ADLN (n = 5 mice/group with pooled samples, for three independent experiments). *P < 0.05 by
one-tailed Mann–Whitney U-Test. WT, wild type; KO, knockout; OVA, ovalbumin.
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Furthermore, there were elevated numbers CD4+ FoxP3-
CD25+ Teff cells in the OVA-challenged KO mice in com-
parison to OVA-challenged WT mice. (Fig. 6B, right
panel).
In summary, the numbers of CD4+ T-cell subsets in
the ADLN of sensitized and OVA-challenged KO mice
were increased when compared to WT mice, suggesting
that a lack of CD103 did not restrict CD4+ T-cell subset
activation or expansion in the ADLN in response to
inhaled allergen, and may perhaps have lead to their
increased retention or reduced emigration.
Discussion
In this study, we have examined the role of CD103 in the
pathogenesis of allergic airways disease using an ovalbu-
min-induced mouse model of EAAD in BALB/c CD103/
 (KO) mice. We found a lack of CD103 lead to signifi-
cantly reduced clinical symptoms of EAAD, including
reduced AHR and airway eosinophilia, when compared to
wild-type (WT) BALB/c mice, suggesting a pathogenic
role for CD103 in the pathogenesis of allergic asthma in
this model. Our data appear to be contradictory to those
of Bernatchez et al. (2015) who showed an exacerbation
of the clinical symptoms of OVA-induced EAAD in
CD103 KO mouse model. The reasons why the two mod-
els differ remains unclear, however, there were a number
of differences in experimental design that may be infor-
mative: Firstly, the Bernatchez study was performed in
CD103 KO mice on a C57BL/6 (B6) background rather
than the BALB/c background used in this study. Genetic
background is known to have a major impact on EAAD
expression in mice, with B6 mice generally showing atten-
uated AHR compared to BLAB/c mice (Ewart et al. 2000;
Elena et al. 2003). Secondly, the number of antigen chal-
lenge doses is known to significantly affect the severity of
methacholine responses in the OVA model: the Ber-
natchez study used a total of five OVA aerosol challenges,
whereas we used a single OVA challenge (Zosky et al.
2004). This was reflected by the high percentages of eosi-
nophils in BALF observed in the Bernatchez study (maxi-
mal of 70%) compared to ours (maximal of 40%), which
may have impacted on the overall expression of clinical
symptoms. Finally, sexual dimorphism is known to play a
significant role in the expression of respiratory inflamma-
tory diseases in mice, with female mice developing more
severe disease in the OVA-induced allergic airways
inflammation model (Melgert et al. 2005). While the Ber-
natchez study specified that sex-matched mice were used,
they did not specify which sex was used for their OVA
studies. While we used only female mice in this study, it
is possible that sexual dimorphism may have had an
impact on the inflammatory responses between the two
studies.
Interestingly, we found that CD103 KO mice developed
significantly elevated levels of circulating OVA-specific
IgE following OVA sensitization when compared to WT
BALB/c mice, suggesting that the reduction in clinical
Figure 6. Airway draining lymph node CD4+ T-cell subset percentages and numbers in OVA-sensitized and challenged BALB/c WT and
CD103/ mice. Adult BALB/c WT and CD103 KO mice were sensitized and challenged with OVA or saline as described for Figure 1. At 24 h
after final aerosol, ADLN were harvested, and single cell suspensions prepared and analyzed by flow cytometry for total CD4+ T cells, CD4+
FoxP3+ CD25+ Treg and CD4
+ FoxP3- CD25+ Teff. (A) Percentages and (B) total numbers of total, Treg and Teff CD4
+ T cells in ADLN of saline- or
OVA-challenged WT or CD103 KO mice. (data are three independent experiments with n = 5 mice/group in pooled samples; means +/ SEM).
*P < 0.05 by one-tailed Mann–Whitney U-Test. ADLN, airway draining lymph node; WT, wild type; KO, knockout; OVA, ovalbumin.
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symptoms seen in CD103 KO mice were not simply due
to a deficiency in systemic sensitization to OVA, or prim-
ing of allergen-specific Th2 cells required for anti-OVA
IgE class switching. The reason for the elevated IgE
response in CD103 KO mice is unknown, but may sug-
gest a role for CD103 in regulating Th2 priming or CD4+
T-cell recirculation to germinal centers. While we did not
perform lavage cytokine analysis in this study, our data
showing that systemic IgE priming to OVA was intact or
exacerbated in CD103 KO mice in the face of reduced
local airway inflammation and AHR suggests a role for
CD103 in regulating the clinical features of EAAD inde-
pendently of systemic allergen sensitization and IgE.
While we were unable to provide a mechanistic basis for
this in the current study, previous studies have shown
that AHR and inflammation are not strictly correlated in
human allergic asthmatic patients (Crimi et al. 1998), and
that inflammation and AHR may be differentially regu-
lated, with the traits controlled at different genetic loci, in
mouse models of EAAD (Brewer et al. 1999; Ewart et al.
2000; Poynter et al. 2004). Our data extend these find-
ings, suggesting that CD103 plays a role in regulating
local airway inflammation and AHR independently of sys-
temic IgE production.
CD103 can be expressed on both CD4 T cells and DC,
two cell types that are centrally implicated in the patho-
genesis of allergic airways disease (Holt et al. 2008). Fur-
thermore, E-cadherin, the ligand for CD103, is expressed
on airway epithelial cells and appears to be important in
the retention and localization of both CD4+ T cells and
DC within the epithelium at the site of antigen exposure
(Nawijn et al. 2011). For these reasons, we hypothesized
that CD103 may play a role regulating local airway DC or
CD4+ T-cell function or activation, or migration of DC
and subsequent CD4+ T-cell priming to inhaled antigens
in airway draining lymph nodes. Our data show that the
numbers of CD4+ T cells in the airways of sensitized and
challenged CD103 KO mice, including effector and regu-
latory T cells, were significantly reduced when compared
to wild-type mice, suggesting that either these T cells
failed to be recruited to the airways following challenge,
or failed to be retained with the airway mucosa. Previous
studies have shown a requirement for CD103 for reten-
tion of CD4+ (regulatory) T cells in the skin during bac-
terial-induced inflammation (Sch€on et al. 1999), while
other studies have shown an essential role for CD4+ T-cell
function in mediating the major clinical signs of EAAD
during the effector phase of the disease (Li et al. 1999).
Our data are consistent with these studies, suggesting that
CD103 is required for recruitment and/or retention of
effector CD4+ T-cell subsets within the airways that are
required to mediate the local expression of clinical dis-
ease, including AHR and recruitment of eosinophils.
In addition to expression by T cells, CD103 is also
expressed on subsets of DC, and in particular those pro-
posed to reside within the airway epithelium (Hammad
and Lambrecht 2008). Interactions between DC and T
cells are crucial to the initiation and maintenance of
inflammation to inhaled allergens (Huh et al. 2003), with
two major subsets of CD11bhi CD103- and CD11blo
CD103+ respiratory DC have been described, each with
proposed differing roles in regulating airway inflamma-
tion (Sung et al. 2006; Beaty et al. 2007). Initially, we
addressed the issue of whether the balance of airway DC
subsets was disrupted in the absence of CD103 as a
potential explanation for the disrupted CD4+ T-cell
responses we observed in CD103 KO mice. Importantly,
in sensitized but saline-exposed mice, total numbers of
airway DC and the proportions of CD11blo and CD11blo
airway DC subsets were similar between KO and WT
mice. However, following specific allergen challenge,
CD103 KO mice failed to recruit DC subsets into the air-
ways to the same extent as WT mice, with DC numbers
not increasing above steady-state levels. As recruitment of
DC to the airways is a hallmark feature of airway mucosal
inflammatory responses (Stumbles et al. 2001), our data
indicate that CD103 is critical for recruitment of DC to
the airways during inflammation, however, is not
required for baseline homeostasis of airway DC numbers
or subset balance. Consistent with this, inhaled allergen
capture by CD11blo and CD11bhi DC subsets in the air-
ways was not markedly disrupted in CD103 KO mice at
early time points (2 h) after exposure, and we also
observed similar rates of egress of antigen-positive cells
from the airways at later time points (24 h) after expo-
sure, although with some suggestion that egress was more
rapid in CD103 KO mice.
However, despite apparently normal levels of allergen
capture by DC in the airways of CD103 KO mice, we did
observe a significant decrease in the absolute numbers of
allergen-laden migratory (CD8a-) DC reaching the airway
draining lymph nodes of CD103 KO mice compared to
WT mice 24 h after allergen challenge. Nevertheless, this
decrease was not reflected by a decreased expansion of
effector or regulatory CD4+ T-cell subsets in the draining
lymph nodes, with CD103 KO mice showing an equiva-
lent or enhanced increase in numbers of total, regulatory
and effector CD4+ T cells after allergen exposure when
compared to WT mice. This suggests that sufficient anti-
gen must have reached the lymph nodes of CD103 KO
mice in order to drive CD4+ T-cell activation and expan-
sion, and indeed we did observe elevated percentage fre-
quencies of antigen-laden CD8a- DC in the ADLN of KO
mice at 24 h compared to 2 h post-i.n. delivery, but at
lower levels than in WT mice. In addition, an absence of
CD103 on T cells may lead to a retention of activated T
ª 2016 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
The Physiological Society and the American Physiological Society.
2016 | Vol. 4 | Iss. 21 | e13021
Page 11
V. S. Fear et al. A Pathogenic Role for CD103 in Allergic Airways Disease
cells in the draining lymph nodes, or may disrupt
CD103-mediated regulatory pathways that have previously
been described involving induction of beta-catenin in
CD103+ DC (Jiang et al. 2007; Manicassamy et al. 2010).
In summary, we have shown that CD103 plays an
important role in the pathogenesis of experimental aller-
gic airways disease in pro-allergic BALB/c mice through
regulation of airway expression of AHR and eosinophilia,
but not in systemic sensitization to allergen or induction
of allergen-specific IgE. We show that CD103 was
required for the recruitment and/or expansion of CD4+ T
cells and subsets of DC within the airways during inflam-
mation, but was not required for maintenance of airway
DC subset homeostasis in the steady-state and its absence
did not influence the capacity of airway DC to capture
inhaled allergen. An absence of CD103 did, however,
reduce the numbers of antigen-laden DC reaching drain-
ing lymph nodes, although this was not reflected by a
reduced expansion of CD4+ T cells with lymph nodes.
Speculatively, our data suggest a dual role for CD103 in
recruiting DC to airways and guiding their migration to
draining lymph nodes during allergic inflammation, as
well for guiding activated CD4+ T cells from lymph nodes
back to the airways in order to mediate the local expres-
sion of allergic airways disease.
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